Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis-Reference-Cited by-同舟云学术

Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis

Published:2014-09-23 Issue:11 Volume:21 Page:1341-1351
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Carr Bruce¹,Dmowski W. Paul²,O’Brien Chris³,Jiang Ping⁴,Burke Joshua³,Jimenez Roland³,Garner Elizabeth⁴,Chwalisz Kristof⁴

Affiliation:

1. Department of Obstetrics and Gynecology, Reproductive Endocrinology & Infertility Fellowship Program, University of Texas Southwestern Medical Center, Dallas, TX, USA

2. Institute for the Study and Treatment of Endometriosis, Oak Brook, IL, USA

3. Neurocrine Biosciences, Inc, San Diego, CA USA

4. AbbVie Inc, North Chicago, IL, USA

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719114549848

Reference25 articles.

1. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

2. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain

3. Progestogens for endometriosis: forward to the past

4. GnRH analogs: Options for endometriosis-associated pain treatment

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action;Pain;2024-07-02

2. Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents;International Journal of Women's Health;2024-02

3. A systematic review to determine use of the Endometriosis Health Profiles to measure quality of life outcomes in women with endometriosis;Human Reproduction Update;2023-11-25

4. Gibt es neue Hoffnungsträger abseits der chirurgischen Endometriosetherapie?;Die Gynäkologie;2023-10-18

5. A review of phase II and III drugs for the treatment and management of endometriosis;Expert Opinion on Emerging Drugs;2023-10-02